Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 1
2005 5
2006 6
2007 4
2008 4
2009 9
2010 3
2011 8
2012 10
2013 6
2014 4
2015 6
2016 3
2017 8
2018 9
2019 5
2020 7
2021 8
2022 7
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Antidromic vasodilatation and the migraine mechanism.
Geppetti P, Rossi E, Chiarugi A, Benemei S. Geppetti P, et al. Among authors: chiarugi a. J Headache Pain. 2012 Mar;13(2):103-11. doi: 10.1007/s10194-011-0408-3. Epub 2011 Dec 27. J Headache Pain. 2012. PMID: 22200764 Free PMC article. Review.
Poly(ADP-ribosyl)ation and stroke.
Chiarugi A. Chiarugi A. Pharmacol Res. 2005 Jul;52(1):15-24. doi: 10.1016/j.phrs.2005.02.018. Pharmacol Res. 2005. PMID: 15911330 Review.
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.
Berger NA, Besson VC, Boulares AH, Bürkle A, Chiarugi A, Clark RS, Curtin NJ, Cuzzocrea S, Dawson TM, Dawson VL, Haskó G, Liaudet L, Moroni F, Pacher P, Radermacher P, Salzman AL, Snyder SH, Soriano FG, Strosznajder RP, Sümegi B, Swanson RA, Szabo C. Berger NA, et al. Among authors: chiarugi a. Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26. Br J Pharmacol. 2018. PMID: 28213892 Free PMC article. Review.
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ).
Onofri A, Iannone LF, Granato A, Garascia G, Bartole L, Manganotti P, Vollono C, Romozzi M, Sottani C, Calabresi P, Tassorelli C, Sances G, Allena M, De Icco R, De Cesaris F, Burgalassi A, Chiarugi A, Baraldi C, Guerzoni S, Prudenzano MP, Fallacara A, Albanese M, Rainero I, Coppola G, Casalena A, Mampreso E, Pistoia F, Sarchielli P, Morson M, Sacco S, Geppetti P, Ornello R; Italian Headache Registry (RICe) Study Group. Onofri A, et al. Among authors: chiarugi a. Neurol Sci. 2023 Aug;44(8):2845-2851. doi: 10.1007/s10072-023-06758-0. Epub 2023 Mar 20. Neurol Sci. 2023. PMID: 36939946 Free PMC article.
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study.
Caponnetto V, Russo A, Silvestro M, Tessitore A, De Icco R, Vaghi G, Sances G, Tassorelli C, Baraldi C, Castro FL, Guerzoni S, Prudenzano MP, Fallacara A, Gentile M, Ornello R, Onofri A, Burgalassi A, Chiarugi A, De Cesaris F, Granato A, Casalena A, De Tommaso M, Mampreso E, Merlo P, Coppola G, Battistini S, Rebecchi V, Rainero I, Sepe FN, Dalla Volta G, Sacco S, Geppetti P, Iannone LF; Italian Headache Registry (RICe) Study Group. Caponnetto V, et al. Among authors: chiarugi a. CNS Drugs. 2023 Dec;37(12):1069-1080. doi: 10.1007/s40263-023-01050-3. Epub 2023 Nov 24. CNS Drugs. 2023. PMID: 37999868 Free PMC article.
113 results